Science Explorer Back to mapMap
Discussion
Researcher · Martha-Maria Hospital · Germany

Wolfgang Schuette

Wolfgang Schuette publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0002-7516-5649 OpenAlex
World rank
#1,546,823
of 7,710,434 ranked researchers
Rank in Germany
#76,279
of 364,343
Works
111
Citations
2.5k
Citations per work
22.9
h-index
24
i10-index 40Top 14% in Pulmonary and Respiratory Medicine
Wolfgang Schuette

What does Wolfgang Schuette research?

Wolfgang Schuette's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 84 works · 75.7% of their workMedicine: 84 works · 75.7% of their workPulmonary and Respiratory Medicine: 44 works · 39.7% of their workOncology: 34 works · 30.6% of their workHematology: 4 works · 3.4% of their workEpidemiology: 2 works · 2.0% of their workEverything else: 18 works · 16.2% of their workLife Sciences: 9 works · 8.1% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 8.1% of their workMolecular Biology: 6 works · 5.7% of their workCancer Research: 3 works · 2.4% of their workTHEIR WORKWolfgang Schuette111works
Life Sciences8%Health Sciences76%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine8475.7%
  2. Everything else1816.2%
    1. Biochemistry, Genetics and Molecular Biology98.1%
  1. 1Pulmonary and Respiratory Medicine40% of their works
  2. 2Oncology31% of their works
  3. 3Molecular Biology6% of their works
  4. 4Hematology3% of their works
  5. 5Cancer Research2% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Wolfgang Schuette's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy1093 topics
  2. Clinical Trials1022 topics
  3. Chemotherapy924 topics
  4. ALK Inhibitors621 topic
  5. EGFR Mutations621 topic
  6. Genomic Profiles401 topic
  7. Small-Cell Lung Cancer401 topic
  8. CT Screening331 topic
  9. Lung Cancer331 topic
  10. Immune Checkpoint Blockade231 topic
  11. PD-1 and PD-L1231 topic
  12. DNA101 topic
  13. Topoisomerases101 topic
  14. Cetuximab91 topic
  15. KRAS Mutations91 topic
  16. Cancer Genomics71 topic
  17. Mutational Signatures71 topic
  18. Neuroendocrine Tumors51 topic
  19. Pancreatic Neuroendocrine Tumors51 topic

Where does Wolfgang Schuette work?

Wolfgang Schuette's main affiliation in the publication record is Martha-Maria Hospital, Germany.

How many publications and citations does Wolfgang Schuette have?

OpenAlex counts 111 works and 2,541 citations for Wolfgang Schuette, an h-index of 24, ranking #1,546,823 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wolfgang Schuette. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.